| Gender | Age | Diagnosis | Lung Injury Score | Respiratory support | ECMO complications | Treatment | BVAS | BVAS | Predicted ICU mortality | ICU survival |
|---|---|---|---|---|---|---|---|---|---|---|
| (years) | (duration in days) | (Pre) | (Post) | (APACHE II) | (LOS in days) | |||||
| Male | 73 | GPA | 3.5 | VV-ECMO (8) | Nil | PEx, MEP, HD, CYC | 10 | 2 | 53.3% | Yes (17) |
| Male | 61 | GPA | 3.5 | VV-ECMO (8) | Nil | PEx, MEP, CYC | 10 | 4 | 29.2% | Yes (14) |
| Female | 54 | MPA | 3.5 | HFOV, Prone | N/A | MEP, CYC | 10 | 4 | 26.2% | Yes (15) |
| Male | 46 | GPA | 3.25 | VV-ECMO (5) | Nil | PEx, MEP, HD, CYC | 15 | 10 | 35.5% | Yes (21) |
MV, mechanical ventilation; LOS, length of stay; GPA, granulomatosis and polyangiitis; MPA, microscopic polyangiitis; PEx, plasma exchange; MEP, methylprednisolone; HD, continuous veno-venous haemodialysis; CYC, cyclophosphamide.